Cargando…
MuLBSTA score in COVID-19 pneumonia and prediction of 14-day mortality risk: A study in an Indian cohort
BACKGROUND: The infectious agent which has caused the COVID-19 pandemic is a coronavirus named SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). On one end of the spectrum, a patient suffering from COVID-19 may be asymptomatic or have mild symptoms, while on the other end of the spectrum...
Autores principales: | Preetam, Mukul, Anurag, Aditya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132828/ https://www.ncbi.nlm.nih.gov/pubmed/34017730 http://dx.doi.org/10.4103/jfmpc.jfmpc_1766_20 |
Ejemplares similares
-
Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score
por: Guo, Lingxi, et al.
Publicado: (2019) -
Erratum: Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score
Publicado: (2020) -
MuLBSTA score is a useful tool for predicting COVID-19 disease behavior
por: Iijima, Yuki, et al.
Publicado: (2021) -
Validation of MuLBSTA score to derive modified MuLB score as mortality risk prediction in COVID-19 infection
por: George, Richie, et al.
Publicado: (2022) -
Applicability of MuLBSTA scoring system as diagnostic and prognostic role in early warning of severe COVID-19
por: Ma, Bei, et al.
Publicado: (2021)